NCT03260712 2023-11-03
Pembrolizumab in Biliary Tract Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
Clinical Trials
9 trialsNCT01917617 2019-02-21
Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group
Phase 2 Completed
NCT02182778 2019-02-21
GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group
Phase 3 Completed
NCT01815307 2018-05-16
Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group
Phase 2 Completed
NCT01297998 2017-11-17
A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
Kansai Hepatobiliary Oncology Group
Phase 1 Completed
NCT01713387 2017-10-09
A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
Kansai Hepatobiliary Oncology Group
Phase 1 Completed
NCT01284413 2014-07-01
Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group
Phase 1/2 Completed
NCT01861483 2014-07-01
Vessel Resection and Reconstruction of Biliary Tract Cancers
Kansai Hepatobiliary Oncology Group
Completed
NCT01294085 2011-11-28
Case Series Study of Biliary Tract Cancer Patients in Japan
Kansai Hepatobiliary Oncology Group
Completed